IL264760A - - Google Patents
Info
- Publication number
- IL264760A IL264760A IL26476019A IL26476019A IL264760A IL 264760 A IL264760 A IL 264760A IL 26476019 A IL26476019 A IL 26476019A IL 26476019 A IL26476019 A IL 26476019A IL 264760 A IL264760 A IL 264760A
- Authority
- IL
- Israel
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662373410P | 2016-08-11 | 2016-08-11 | |
| PCT/US2017/046237 WO2018031738A2 (en) | 2016-08-11 | 2017-08-10 | Ischemia/reperfusion injury |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL264760A true IL264760A (https=) | 2019-03-31 |
| IL264760B1 IL264760B1 (en) | 2023-03-01 |
| IL264760B2 IL264760B2 (en) | 2023-07-01 |
Family
ID=61162527
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL264760A IL264760B2 (en) | 2016-08-11 | 2019-02-10 | Regional ischemia/reperfusion injury |
| IL300767A IL300767B1 (en) | 2016-08-11 | 2023-02-19 | Regional ischemia/reperfusion injury |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL300767A IL300767B1 (en) | 2016-08-11 | 2023-02-19 | Regional ischemia/reperfusion injury |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190183971A1 (https=) |
| EP (1) | EP3496726A4 (https=) |
| JP (1) | JP7164885B2 (https=) |
| KR (2) | KR20240130829A (https=) |
| CN (1) | CN109937045A (https=) |
| AU (2) | AU2017311405B2 (https=) |
| CA (1) | CA3033633A1 (https=) |
| IL (2) | IL264760B2 (https=) |
| MX (1) | MX2019001729A (https=) |
| WO (1) | WO2018031738A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110438159B (zh) * | 2019-07-03 | 2023-02-28 | 广州中医药大学(广州中医药研究院) | 一种引发肌原纤维肌病的基因突变小鼠模型的构建方法 |
| CN113082048B (zh) * | 2021-05-08 | 2022-06-10 | 中国人民解放军陆军军医大学第二附属医院 | 一种Se@BSA纳米药物的制备方法及其在急性肾损伤中的应用 |
| CN113502260A (zh) * | 2021-07-16 | 2021-10-15 | 新疆医科大学第一附属医院 | 一种小鼠乳鼠原代心肌细胞分离与培养方法及其应用 |
| JP2025514489A (ja) * | 2022-05-03 | 2025-05-02 | テンプル ユニバーシティー オブ ザ コモンウェルス システム オブ ハイアー エデュケーション | 脳におけるｂａｇ３およびタンパク質品質管理 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834248A (en) * | 1995-02-10 | 1998-11-10 | Millennium Pharmaceuticals Inc. | Compositions and methods using rchd534, a gene uregulated by shear stress |
| US20030175958A1 (en) * | 2002-03-15 | 2003-09-18 | Reed John C. | Methods for using bag expression as a cell differentiation agent and marker |
| CN102170911B (zh) | 2008-08-01 | 2014-07-02 | 克里夫兰生物实验室公司 | 用于治疗再灌注损伤的方法 |
| KR101436684B1 (ko) * | 2012-03-09 | 2014-09-01 | 가톨릭대학교 산학협력단 | 저산소성 허혈 예방 또는 치료용 조성물 |
| WO2015117010A2 (en) * | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 as a target for therapy of heart failure |
-
2017
- 2017-08-10 KR KR1020247027801A patent/KR20240130829A/ko active Pending
- 2017-08-10 JP JP2019529143A patent/JP7164885B2/ja active Active
- 2017-08-10 CA CA3033633A patent/CA3033633A1/en active Pending
- 2017-08-10 CN CN201780062730.6A patent/CN109937045A/zh active Pending
- 2017-08-10 AU AU2017311405A patent/AU2017311405B2/en active Active
- 2017-08-10 MX MX2019001729A patent/MX2019001729A/es unknown
- 2017-08-10 EP EP17840255.8A patent/EP3496726A4/en active Pending
- 2017-08-10 US US16/324,719 patent/US20190183971A1/en not_active Abandoned
- 2017-08-10 WO PCT/US2017/046237 patent/WO2018031738A2/en not_active Ceased
- 2017-08-10 KR KR1020197007013A patent/KR20190042609A/ko not_active Ceased
-
2019
- 2019-02-10 IL IL264760A patent/IL264760B2/en unknown
-
2022
- 2022-11-04 US US18/052,863 patent/US20230390357A1/en not_active Abandoned
-
2023
- 2023-02-19 IL IL300767A patent/IL300767B1/en unknown
- 2023-09-28 AU AU2023237152A patent/AU2023237152B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019527736A (ja) | 2019-10-03 |
| IL264760B1 (en) | 2023-03-01 |
| AU2023237152B2 (en) | 2026-01-22 |
| EP3496726A4 (en) | 2020-05-06 |
| KR20240130829A (ko) | 2024-08-29 |
| KR20190042609A (ko) | 2019-04-24 |
| US20190183971A1 (en) | 2019-06-20 |
| CN109937045A (zh) | 2019-06-25 |
| IL300767A (en) | 2023-04-01 |
| CA3033633A1 (en) | 2018-02-15 |
| MX2019001729A (es) | 2019-11-12 |
| US20230390357A1 (en) | 2023-12-07 |
| AU2023237152A1 (en) | 2023-10-19 |
| JP7164885B2 (ja) | 2022-11-02 |
| IL264760B2 (en) | 2023-07-01 |
| WO2018031738A2 (en) | 2018-02-15 |
| EP3496726A2 (en) | 2019-06-19 |
| IL300767B1 (en) | 2026-03-01 |
| AU2017311405B2 (en) | 2023-07-13 |
| AU2017311405A1 (en) | 2019-02-28 |